Lisa Maurer
Avon
Alzheimer’s disease has had such a profound effect on our family. My husband, Mike, and I witnessed his mom, Jeanette, and sister, Suzanne, suffer and pass away from Alzheimer’s disease.
After several years of concern, Mike was officially diagnosed with young-onset Alzheimer’s in November 2022 at the age of 59.
That’s why I am writing to ask my congressperson, Rep. Michelle Fischbach, for her support of bipartisan legislation in the U.S. Congress, the National Alzheimer’s Project Act and the Alzheimer’s Accountability and Investment Act.
NAPA, signed into law in 2011, has played a crucial role in coordinating efforts across federal agencies to combat Alzheimer’s disease. And the AAIA is essential for ensuring transparency and accountability in the allocation of funds for Alzheimer’s research. It’s critical that Congress reauthorize these programs this year.
Rep. Fischbach’s involvement as a co-sponsor of NAPA and AAIA would not only reflect our district’s commitment to the well-being of its constituents but also underscore the importance of a unified effort at the federal level.
As a volunteer with the Alzheimer’s Association, I also want to remind everyone they offer free classes on Alzheimer’s and dementia and support groups for people impacted. Visit alz.org/mnnd or call the 24/7 Helpline at 800-272-3900 for support.